MarketCapTrends
SLXN
Silexion Therapeutics Corp. (SLXN)
NASDAQ · Healthcare

Silexion Therapeutics Corp. Cash on Hand 2023–2025

Silexion Therapeutics Corp. annual/quarterly cash on hand history from 2023 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.

  • Silexion Therapeutics Corp. cash on hand for the quarter ending December 31, 2025 were 6.0M, a 404.72% increase year-over-year.
  • Silexion Therapeutics Corp. cash on hand for 2025 were 6.0M, a 404.72% increase from 2024.
  • Silexion Therapeutics Corp. cash on hand for 2024 were 1.2M, a 74.17% decrease from 2023.
  • Silexion Therapeutics Corp. cash on hand for 2023 were 4.6M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Silexion Therapeutics Corp. Annual Cash on Hand (Millions of US $)
2025$6
2024$1
2023$5
Silexion Therapeutics Corp. Quarterly Cash on Hand (Millions of US $)
2025-12-31$6
2024-12-31$1
2023-12-31$5

Silexion Therapeutics Corp. Cash on Hand — FAQ

Silexion Therapeutics Corp. (SLXN) cash on hand over the last 3 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see SLXN's cash on hand history?

The chart and table above show Silexion Therapeutics Corp.'s cash on hand by year and by quarter, including the growth rate.